• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C/EBPδ是白细胞介素-6诱导的前列腺癌细胞生长抑制的下游介质。

C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.

作者信息

Sanford Daniel C, DeWille James W

机构信息

Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, USA.

出版信息

Prostate. 2005 May 1;63(2):143-54. doi: 10.1002/pros.20159.

DOI:10.1002/pros.20159
PMID:15486993
Abstract

BACKGROUND

Although a number of reports have investigated the effects of IL-6 family cytokines on prostate cell growth, there is limited information available identifying IL-6 inducible downstream effector genes and their function in growth control. Previous studies have demonstrated that IL-6 treatment results in the activation of signal transducer and activator of transcription3 (STAT3) in prostate cancer cells. The goal of this study was to investigate the influence of IL-6 treatment and activation of the Jak/STAT signal transduction pathway on C/EBPdelta gene expression and growth inhibition of human prostate cancer cells.

METHODS

Expression of C/EBPdelta and STAT3 activation were assayed using Northern and Western blotting techniques. Proliferation was assessed by [(3)H] thymidine incorporation, flow cytometry, and colony formation analyses. The analysis of the transcriptional regulation of C/EBPdelta was performed using luciferase-reporter constructs.

RESULTS

In this report, we demonstrate that IL-6 treatment induces STAT3 activation (pSTAT3), pSTAT3 binds to the human C/EBPdelta gene promoter and induces its expression. We also demonstrate that C/EBPdelta over-expression is capable of suppressing prostate cancer cell growth.

CONCLUSIONS

These results demonstrate that C/EBPdelta gene expression is increased in IL-6 treated LNCaP cells. Increased C/EBPdelta gene expression plays an important role in IL-6/STAT3 mediated growth arrest of LNCaP prostate cancer cells. Ongoing studies are investigating the mechanism by which C/EBPdelta controls prostate cancer cell growth and the potential role of C/EBPdelta in the survival and chemo resistance of prostate cancer metastasis. (c) 2004 Wiley-Liss, Inc.

摘要

背景

尽管已有多项报道研究了白细胞介素-6(IL-6)家族细胞因子对前列腺细胞生长的影响,但关于鉴定IL-6诱导的下游效应基因及其在生长控制中的功能的信息有限。先前的研究表明,IL-6处理可导致前列腺癌细胞中信号转导子和转录激活子3(STAT3)的激活。本研究的目的是探讨IL-6处理和Jak/STAT信号转导通路的激活对人前列腺癌细胞C/EBPδ基因表达和生长抑制的影响。

方法

使用Northern和Western印迹技术检测C/EBPδ的表达和STAT3的激活。通过[³H]胸苷掺入、流式细胞术和集落形成分析评估细胞增殖。使用荧光素酶报告构建体对C/EBPδ的转录调控进行分析。

结果

在本报告中,我们证明IL-6处理可诱导STAT3激活(pSTAT3),pSTAT3与人C/EBPδ基因启动子结合并诱导其表达。我们还证明C/EBPδ的过表达能够抑制前列腺癌细胞的生长。

结论

这些结果表明,在IL-6处理的LNCaP细胞中C/EBPδ基因表达增加。C/EBPδ基因表达的增加在IL-6/STAT3介导的LNCaP前列腺癌细胞生长停滞中起重要作用。正在进行的研究正在探讨C/EBPδ控制前列腺癌细胞生长的机制以及C/EBPδ在前列腺癌转移的存活和化疗耐药中的潜在作用。(c)2004威利-利斯公司。

相似文献

1
C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.C/EBPδ是白细胞介素-6诱导的前列腺癌细胞生长抑制的下游介质。
Prostate. 2005 May 1;63(2):143-54. doi: 10.1002/pros.20159.
2
CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.CCAAT/增强子结合蛋白δ(c/EBPδ)在人乳腺上皮细胞中的调控与表达:I. 乳腺癌细胞系中c/EBPδ生长抑制途径的“功能丧失”改变。
J Cell Biochem. 2004 Nov 1;93(4):830-43. doi: 10.1002/jcb.20223.
3
CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control.CCAAT/增强子结合蛋白δ(c/EBPδ)在人乳腺上皮细胞中的调控与表达:II. 激活信号转导途径、转录、转录后及翻译后控制的分析
J Cell Biochem. 2004 Nov 1;93(4):844-56. doi: 10.1002/jcb.20224.
4
Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.核因子κB p50/p65、Fra-1和JunD的组成性激活对于前列腺癌中白细胞介素6表达失调至关重要。
Cancer Res. 2003 May 1;63(9):2206-15.
5
Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.成纤维细胞生长因子-1转录诱导前列腺癌细胞系中膜型-1基质金属蛋白酶的表达。
Prostate. 2004 Jan 1;58(1):66-75. doi: 10.1002/pros.10293.
6
Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.前列腺癌中的生长激素(GH)受体:在人体组织和细胞系中的基因表达及特性、LNCaP细胞中的GH信号传导与雄激素受体调控
Mol Cell Endocrinol. 2004 May 31;220(1-2):109-23. doi: 10.1016/j.mce.2004.03.004.
7
Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.白细胞介素6通过信号转导和转录激活因子3依赖性途径激活LNCaP前列腺癌细胞中雄激素受体介导的基因表达。
Cancer Res. 2000 Apr 15;60(8):2132-5.
8
Mechanisms by which interleukin-6 regulates prostate-specific antigen gene expression in prostate LNCaP carcinoma cells.白细胞介素-6调节前列腺LNCaP癌细胞中前列腺特异性抗原基因表达的机制。
J Androl. 2011 Jul-Aug;32(4):383-93. doi: 10.2164/jandrol.109.009878. Epub 2010 Nov 4.
9
The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression.小鼠C/EBPδ基因启动子受STAT3和Sp1转录激活因子、染色质重塑及c-Myc抑制的调控。
J Cell Biochem. 2007 Dec 1;102(5):1256-70. doi: 10.1002/jcb.21356.
10
CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.CCAAT/增强子结合蛋白δ:1,25-二羟基维生素D3在雄激素反应性前列腺癌LNCaP细胞中的分子靶点。
Cancer Res. 2005 Jun 1;65(11):4762-8. doi: 10.1158/0008-5472.CAN-03-3619.

引用本文的文献

1
Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo.Curaxin CBL0137对血液系统恶性肿瘤的体内外靶向作用特征
Biomedicines. 2023 Jan 16;11(1):230. doi: 10.3390/biomedicines11010230.
2
Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression.CEBPD-hsa-miR-429-VEGFA 信号轴驱动的血管生成促进尿路上皮癌进展。
Cells. 2022 Feb 11;11(4):638. doi: 10.3390/cells11040638.
3
MCL1 participates in leptin-promoted mitochondrial fusion and contributes to drug resistance in gallbladder cancer.
MCL1 参与瘦素促进的线粒体融合,并有助于胆囊癌的耐药性。
JCI Insight. 2021 Aug 9;6(15):e135438. doi: 10.1172/jci.insight.135438.
4
High-Throughput Screening for CEBPD-Modulating Compounds in THP-1-Derived Reporter Macrophages Identifies Anti-Inflammatory HDAC and BET Inhibitors.高通量筛选 THP-1 衍生报告巨噬细胞中 CEBPD 调节剂化合物,鉴定抗炎 HDAC 和 BET 抑制剂。
Int J Mol Sci. 2021 Mar 16;22(6):3022. doi: 10.3390/ijms22063022.
5
CCAAT/Enhancer-Binding Protein Delta (C/EBPδ): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcinoma Cells.CCAAT/增强子结合蛋白δ(C/EBPδ):一种先前未被认识的肿瘤抑制因子,可限制胰腺导管腺癌细胞的致癌潜能。
Cancers (Basel). 2020 Sep 7;12(9):2546. doi: 10.3390/cancers12092546.
6
Transcriptional Factors and Protein Biomarkers as Target Therapeutics in Traumatic Spinal Cord and Brain Injury.转录因子和蛋白质生物标志物作为创伤性脊髓和脑损伤的靶向治疗药物。
Curr Neuropharmacol. 2020;18(11):1092-1105. doi: 10.2174/1570159X18666200522203542.
7
Maternal administration of probiotics promotes brain development and protects offspring's brain from postnatal inflammatory insults in C57/BL6J mice.母体给予益生菌可促进大脑发育,并保护 C57/BL6J 幼鼠的大脑免受产后炎症的损伤。
Sci Rep. 2020 May 18;10(1):8178. doi: 10.1038/s41598-020-65180-0.
8
IL-6 signaling contributes to radioresistance of prostate cancer through key DNA repair-associated molecules ATM, ATR, and BRCA 1/2.IL-6 信号通过关键的 DNA 修复相关分子 ATM、ATR 和 BRCA1/2 促进前列腺癌的放射抵抗。
J Cancer Res Clin Oncol. 2019 Jun;145(6):1471-1484. doi: 10.1007/s00432-019-02917-z. Epub 2019 Apr 24.
9
In-Silico Integration Approach to Identify a Key miRNA Regulating a Gene Network in Aggressive Prostate Cancer.基于计算机的整合方法识别调控侵袭性前列腺癌基因网络的关键 miRNA。
Int J Mol Sci. 2018 Mar 19;19(3):910. doi: 10.3390/ijms19030910.
10
The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.C/EBPδ蛋白通过雌激素受体α活性得以稳定,抑制SNAI2表达,并与乳腺癌的良好预后相关。
Oncogene. 2016 Dec 1;35(48):6166-6176. doi: 10.1038/onc.2016.156. Epub 2016 May 16.